MDNews - Lower Hudson/Bronx

November 2013

Issue link: https://viewer.e-digitaledition.com/i/205083

Contents of this Issue

Navigation

Page 18 of 35

ReSeARCH INTo THe human microbiome is ramping up on a national level, and researchers at montefiore medical Center are playing an important part, says allan W. Wolkoff, mD, Chief of the Division of Gastroenterology and Liver Diseases and Director of the marion Bessin Liver Research Center at montefiore medical Center and albert Einstein College of medicine. "this is a new field," Dr. Wolkoff says. "a few years ago, we recognized bacteria live in the gut, but we left it at that. it's now become clear that the mix of bacteria in each colon varies and that individuals are likely to have different colonic ecosystems." Filtered stool suspension in syringes, soon to be injected into the colon via colonoscopy the national initiative aims to identify the human body's individual bacterial inhabitants, but to do so, Washington-based researchers need reliable methods for storage and transportation — the focus of one group of montefiore researchers. + have had no exposure to antibiotics within the last three months "Ongoing studies throughout the country are under way that involve sending samples for analysis," Dr. Wolkoff notes. "When you get a fecal sample and want to understand bacteria contained + have no recent tattoos or body piercings therein, how do you store it and send it to the lab? this sounds like a simple consideration, but this represents the foundation of the + are in good health larger scope of microbial studies, and we have to get this right to advance." + have no history of cancer, compromised immune system, diabetes, diarrhea, inflammatory bowel disease, irritable bowel syndrome, diarrhea, constipation, severe allergic disorders, major systemic illnesses, metabolic syndrome or obesity As FMT reaches a wider audience, some people have performed FMT on themselves in their homes. This completely circumvents safe screening and increases the risk of disease transmission. Dr. Brandt encourages those considering FMT to have the procedure performed in a hospital setting with all necessary safeguards in place. A long Road Dr. Brandt realized the benefits of FMT early on, but in 1998, the procedure didn't garner commendation or glory. "I was accused of quackery," Dr. Brandt says. "At first, people laughed at me, and as the procedure gained popularity, there was still a current of derision. To a large measure, patients' acceptance in those days was predicated by their physicians' attitudes about it, but early on, physicians were just as resistant to the concept as patients." Now, patients seek Dr. Brandt for FMT and relief from refractory C. diff. As patients become more informed about the procedure's benefits, the subject is no longer met with criticism. "I don't have to convince my patients of anything," Dr. Brandt says. "They come to me because they have sought answers. These patients are Internet-savvy or have Internet-knowledgeable friends or relatives. They're well-educated, well-informed and know about FMT. They've researched the topic and know about speCial CliniCal seCtion: GASTRoeNTeRoloGY b rUs h stro k es i n a b iGG er piC tU r e me and what I do. They come to me to have the procedure, not to discuss it." The Art of Medicine Physicians have demonstrated the procedure's efficacy but have yet to pinpoint the mechanism behind it. Being on the leading edge isn't always a popular place, and FMT is no exception. In fact, until recently, the U.S. Food and Drug Administration (FDA) required Investigational New Drug (IND) requests for use of FMT in patients with refractory C. diff infection, as the therapy is still considered experimental. (Physicians still need IND approval to perform FMT on patients with any other condition, though Dr. Brandt has seen "unquestionably positive results" in patients with irritable bowel syndrome and ulcerative colitis.) The procedure will remain investigational until scientists fully comprehend the mechanism behind it, but they're making progress. Researchers at Montefiore Medical Center are working diligently to study better delivery systems for bacterial treatments. "The hope is that in the not-too-distant future, we will be able to identify which bacteria are necessary to control this infection and be able to package them in oral capsules that deliver the bacteria to the intestine and reestablish harmonious distribution," Dr. Wolkoff says. "In this way, we go from the art of medicine, where important observations have been made, to utilizing the incredible science available and narrowing the focus to only a few bacteria." MDNeWS.CoM ■ MD News Lower Hudson/Bronx | 19

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - November 2013